Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (361-370 of 495) with videos related to

Pageof 50
Sort By:
Annals of Diagnostic Pathology|August 27, 2022
Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumorsRia Uhlig, Moussa Abboud, Natalia Gorbokon, et al.
The Journal of Clinical Investigation|February 3, 2026
Overexpression of the ERG oncogene in prostate cancer identifies candidates for PARP inhibitor-based radiosensitizationSabrina Köcher, Mohamed E Elsesy, Ayham Moustafa, et al.
Peerj|August 20, 2021
DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressivenessKristina Jansen, Franziska Büscheck, Katharina Moeller, et al.
Oncotarget|April 19, 2017
Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancerChristoph Burdelski, Laura Borcherding, Martina Kluth, et al.
The Journal of Pathology|January 19, 2023
Automated Ki-67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistryNiclas C Blessin, Cheng Yang, Tim Mandelkow, et al.
Diagnostics (Basel, Switzerland)|March 29, 2023
Mammaglobin-A Expression Is Highly Specific for Tumors Derived from the Breast, the Female Genital Tract, and the Salivary GlandNatalia Gorbokon, Patrick Timm, David Dum, et al.
Oncotarget|January 7, 2020
Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusionStefan Steurer, Lara Schwemmer, Claudia Hube-Magg, et al.
Oncotarget|September 20, 2019
Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissuesSarah Bonk, Martina Kluth, Claudia Hube-Magg, et al.
Neoplasia (New York, N.Y.)|August 6, 2019
Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical ProstatectomySarah Minner, Dominik Hager, Stefan Steurer, et al.
Plos One|February 9, 2013
Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancersMaria B Raeder, Even Birkeland, Jone Trovik, et al.
Pageof 50

Showing results (361-370 of 495) with videos related to

Sort By:
Pageof 50
Annals of Diagnostic Pathology|August 27, 2022
Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumorsRia Uhlig, Moussa Abboud, Natalia Gorbokon, et al.
The Journal of Clinical Investigation|February 3, 2026
Overexpression of the ERG oncogene in prostate cancer identifies candidates for PARP inhibitor-based radiosensitizationSabrina Köcher, Mohamed E Elsesy, Ayham Moustafa, et al.
Peerj|August 20, 2021
DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressivenessKristina Jansen, Franziska Büscheck, Katharina Moeller, et al.
Oncotarget|April 19, 2017
Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancerChristoph Burdelski, Laura Borcherding, Martina Kluth, et al.
The Journal of Pathology|January 19, 2023
Automated Ki-67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistryNiclas C Blessin, Cheng Yang, Tim Mandelkow, et al.
Diagnostics (Basel, Switzerland)|March 29, 2023
Mammaglobin-A Expression Is Highly Specific for Tumors Derived from the Breast, the Female Genital Tract, and the Salivary GlandNatalia Gorbokon, Patrick Timm, David Dum, et al.
Oncotarget|January 7, 2020
Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusionStefan Steurer, Lara Schwemmer, Claudia Hube-Magg, et al.
Oncotarget|September 20, 2019
Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissuesSarah Bonk, Martina Kluth, Claudia Hube-Magg, et al.
Neoplasia (New York, N.Y.)|August 6, 2019
Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical ProstatectomySarah Minner, Dominik Hager, Stefan Steurer, et al.
Plos One|February 9, 2013
Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancersMaria B Raeder, Even Birkeland, Jone Trovik, et al.
Pageof 50